SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-008845
Filing Date
2020-05-14
Accepted
2020-05-14 17:24:43
Documents
70
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2313265
2 ex31-1.htm EX-31.1 22430
3 ex31-2.htm EX-31.2 22164
4 ex32-1.htm EX-32.1 6639
5 ex32-2.htm EX-32.2 6577
  Complete submission text file 0001493152-20-008845.txt   6848912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE matn-20191231.xml EX-101.INS 870189
7 XBRL SCHEMA FILE matn-20191231.xsd EX-101.SCH 64548
8 XBRL CALCULATION FILE matn-20191231_cal.xml EX-101.CAL 53145
9 XBRL DEFINITION FILE matn-20191231_def.xml EX-101.DEF 327199
10 XBRL LABEL FILE matn-20191231_lab.xml EX-101.LAB 426430
11 XBRL PRESENTATION FILE matn-20191231_pre.xml EX-101.PRE 395251
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 20879133
SIC: 2834 Pharmaceutical Preparations